Pages that link to "Q34571644"
Jump to navigation
Jump to search
The following pages link to Targeting adenosine A2A receptors in Parkinson's disease (Q34571644):
Displaying 50 items.
- Dopamine dysregulation in a mouse model of paroxysmal nonkinesigenic dyskinesia (Q24300992) (← links)
- Integrated signaling in heterodimers and receptor mosaics of different types of GPCRs of the forebrain: relevance for schizophrenia (Q24632803) (← links)
- Adenosine signaling and function in glial cells (Q24634273) (← links)
- Nucleus accumbens adenosine A2A receptors regulate exertion of effort by acting on the ventral striatopallidal pathway (Q24646576) (← links)
- A2A receptors in inflammation and injury: lessons learned from transgenic animals (Q24652486) (← links)
- The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist (Q24654563) (← links)
- Potential therapeutic interest of adenosine A2A receptors in psychiatric disorders (Q24657796) (← links)
- Neural control of the lower urinary tract (Q26828785) (← links)
- Therapy for Parkinson's disease: what is in the pipeline? (Q26991826) (← links)
- Mechanisms of chemotherapy-induced behavioral toxicities (Q26998870) (← links)
- The effects of systemic, intrastriatal, and intrapallidal injections of caffeine and systemic injections of A2A and A1 antagonists on forepaw stepping in the unilateral 6-OHDA-lesioned rat (Q28293887) (← links)
- Striatal pre- and postsynaptic profile of adenosine A(2A) receptor antagonists (Q28476722) (← links)
- Neurochemical measurement of adenosine in discrete brain regions of five strains of inbred mice (Q28541087) (← links)
- Unprecedented therapeutic potential with a combination of A2A/NR2B receptor antagonists as observed in the 6-OHDA lesioned rat model of Parkinson's disease (Q28542729) (← links)
- A2A adenosine receptor antagonism enhances synaptic and motor effects of cocaine via CB1 cannabinoid receptor activation (Q28728678) (← links)
- Adenosine receptors as drug targets--what are the challenges? (Q29346491) (← links)
- Mutation in ADORA1 identified as likely cause of early-onset parkinsonism and cognitive dysfunction. (Q29347530) (← links)
- G protein-coupled receptor heterocomplexes in neuropsychiatric disorders. (Q30385233) (← links)
- Novel Therapeutic GPCRs for Psychiatric Disorders (Q30407406) (← links)
- Adenosine A2A receptor signaling and golf assembly show a specific requirement for the gamma7 subtype in the striatum (Q30430643) (← links)
- Adenosine receptor A2A deficiency in leukocytes increases arterial neointima formation in apolipoprotein E-deficient mice (Q30432457) (← links)
- Inactivation of the adenosine A2A receptor protects apolipoprotein E-deficient mice from atherosclerosis (Q30435620) (← links)
- Identification of zebrafish A2 adenosine receptors and expression in developing embryos (Q30436906) (← links)
- Suppression of inflammatory and immune responses by the A(2A) adenosine receptor: an introduction (Q30440124) (← links)
- Adenosine A(2A) Receptor Antagonists Do Not Disrupt Rodent Prepulse Inhibition: An Improved Side Effect Profile in the Treatment of Parkinson's Disease (Q30472044) (← links)
- Adenosine A(2A) receptors in psychopharmacology: modulators of behavior, mood and cognition (Q30482913) (← links)
- Adenosine A(2A) receptor mediates microglial process retraction (Q30488894) (← links)
- Dichotomous dopaminergic control of striatal synaptic plasticity (Q30493521) (← links)
- Systemic inflammation regulates microglial responses to tissue damage in vivo (Q30643015) (← links)
- Cocaine exposure modulates dopamine and adenosine signaling in the fetal brain (Q33618429) (← links)
- Inactivation of neuronal forebrain A receptors protects dopaminergic neurons in a mouse model of Parkinson's disease (Q33645872) (← links)
- Adenosine A2A receptor antagonism reverses inflammation-induced impairment of microglial process extension in a model of Parkinson's disease (Q33811654) (← links)
- Drosophila Models of Parkinson's Disease (Q33817688) (← links)
- Using caffeine and other adenosine receptor antagonists and agonists as therapeutic tools against neurodegenerative diseases: a review. (Q33971113) (← links)
- Adenosine signaling during acute and chronic disease states (Q34035228) (← links)
- Decaffeinated coffee and nicotine-free tobacco provide neuroprotection in Drosophila models of Parkinson's disease through an NRF2-dependent mechanism (Q34111402) (← links)
- Xanthines as Adenosine Receptor Antagonists (Q34139398) (← links)
- Synthesis and evaluation of 1,2,4-triazolo[1,5-c]pyrimidine derivatives as A2A receptor-selective antagonists (Q34157260) (← links)
- Astrocytes and Therapeutics for Parkinson's Disease (Q34168266) (← links)
- Theoretical considerations on the topological organization of receptor mosaics (Q34171499) (← links)
- Pharmacophore mapping and in silico screening to identify new potent leads for A(2A) adenosine receptor as antagonists (Q34183010) (← links)
- Protective effect of metabotropic glutamate mGluR5 receptor elimination in a 6-hydroxydopamine model of Parkinson's disease (Q34269340) (← links)
- Efficient determination of purine metabolites in brain tissue and serum by high-performance liquid chromatography with electrochemical and UV detection (Q34295209) (← links)
- Fluorescent protein complementation assays: new tools to study G protein-coupled receptor oligomerization and GPCR-mediated signaling. (Q34345068) (← links)
- Uncovering caffeine's adenosine A2A receptor inverse agonism in experimental parkinsonism (Q34576218) (← links)
- Modulation of neuroimmunity by adenosine and its receptors: metabolism to mental illness (Q34615473) (← links)
- Adenosinergic depression of glutamatergic transmission in the entorhinal cortex of juvenile rats via reduction of glutamate release probability and the number of releasable vesicles (Q34685689) (← links)
- Dopamine-Mediated Learning and Switching in Cortico-Striatal Circuit Explain Behavioral Changes in Reinforcement Learning (Q34726418) (← links)
- Modulators of nucleoside metabolism in the therapy of brain diseases. (Q34842250) (← links)
- Pathophysiological roles for purines: adenosine, caffeine and urate (Q35008049) (← links)